Original post:
Entasis Therapeutics Introduces First-in-Class Candidate, ETX0462, and Presents Data on SUL-DUR and ETX0282CPDP at World Microbe Forum

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh